Published in Biomed Environ Mass Spectrom on April 01, 1987
Validation of a thin-layer chromatography for the determination of hydrocortisone acetate and lidocaine in a pharmaceutical preparation. ScientificWorldJournal (2014) 0.81
Protocatechuic acid induces cell death in HepG2 hepatocellular carcinoma cells through a c-Jun N-terminal kinase-dependent mechanism. Cell Biol Toxicol (2006) 1.35
Enantioselective aspects of drug action and disposition: therapeutic pitfalls. J Pharm Sci (1989) 1.31
Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92. J Hematother Stem Cell Res (2001) 1.18
Metabolism of amphetamines. Identification of N-oxygenated products by gas chromatography and mass spectrometry. J Pharm Pharmacol (1973) 1.10
Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol. Cell Mol Neurobiol (1997) 1.01
Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent. Can J Physiol Pharmacol (1999) 0.98
Synthesis of N-propargylphenelzine and analogues as neuroprotective agents. Bioorg Med Chem Lett (2001) 0.97
Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica (1999) 0.94
Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos (1997) 0.92
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Antimicrob Agents Chemother (1989) 0.91
Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats. Life Sci (1999) 0.90
The effects of exercise on the pharmacokinetics of drugs. J Pharm Pharm Sci (2001) 0.89
Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review. Curr Med Res Opin (1989) 0.88
Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) antidepressants. Neurosci Biobehav Rev (1998) 0.88
Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates. Pharm Res (1988) 0.87
Comparison of chemical components and antioxidants capacity of different Echinacea species. J Pharm Pharmacol (2001) 0.86
Ethnopharmacology of rhinoceros horn. I: Antipyretic effects of rhinoceros horn and other animal horns. J Ethnopharmacol (1990) 0.86
Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection. J Chromatogr (1992) 0.85
Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection. J Chromatogr B Biomed Sci Appl (2000) 0.84
Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacol (2000) 0.83
Metabolism of some "second"- and "fourth"-generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine. Cell Mol Neurobiol (1999) 0.83
Stereoselective gas chromatographic analysis of etodolac enantiomers in human plasma and urine. J Chromatogr (1986) 0.83
Phenylethylaminergic mechanisms in attention-deficit disorder. Biol Psychiatry (1991) 0.83
Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity. Pediatrics (1987) 0.82
Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.82
Interactions of iprindole with fenfluramine metabolism in rat brain and liver. J Psychiatry Neurosci (1991) 0.82
Phylogenetic relationships and evolutionary history of the shrimp genus Penaeus s.l. derived from mitochondrial DNA. Mol Phylogenet Evol (2004) 0.82
Moclobemide excretion in human breast milk. Br J Clin Pharmacol (1990) 0.82
Influence of cimetidine coadministration on the pharmacokinetics of sotalol enantiomers in an anaesthetized rat model: evidence supporting active renal excretion of sotalol. Biopharm Drug Dispos (1996) 0.82
The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology (Berl) (1996) 0.82
Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA). J Affect Disord (1991) 0.82
Ethnopharmacology of rhinoceros horn. II: Antipyretic effects of prescriptions containing rhinoceros horn or water buffalo horn. J Ethnopharmacol (1991) 0.82
Propofol and thiopental in a 1:1 volume mixture is chemically stable. Anesth Analg (1998) 0.82
Dose-dependent pharmacokinetics of metoclopramide in rat: an effect of hemoperfusion? J Pharmacol Exp Ther (1981) 0.82
Analytical and semi-preparative high-performance liquid chromatographic separation and assay of hydroxychloroquine enantiomers. J Chromatogr (1992) 0.81
Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers. Eur J Clin Pharmacol (1996) 0.81
Expression of SCM-1alpha/lymphotactin and SCM-1beta in natural killer cells is upregulated by IL-2 and IL-12. DNA Cell Biol (1999) 0.81
Character of adverse effects of prophylactic lidocaine in the coronary care unit. Clin Pharmacol Ther (1986) 0.81
Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data. Dev Pharmacol Ther (1988) 0.80
Linearity of metoclopramide kinetics at doses of 5-20 mg. Br J Clin Pharmacol (1988) 0.80
Chemical and pharmacological evaluation of Hypericum perforatum extracts. Acta Pharmacol Sin (2000) 0.80
Stereospecific high-performance liquid chromatographic assay of lomefloxacin in human plasma. J Pharm Biomed Anal (1995) 0.80
Reconstitution of biological molecular generators of electric current. Cytochrome oxidase. J Biol Chem (1976) 0.80
Urinary excretion of phenolic metabolites of N-(n-propyl)amphetamine in man. Res Commun Chem Pathol Pharmacol (1977) 0.80
Metabolism in vitro of N-methylamphetamine with rat liver homogenates. Biochem Pharmacol (1977) 0.80
Liquid-chromatographic assay of ibuprofen enantiomers in plasma. Clin Chem (1988) 0.80
Effect of experimental diabetes mellitus and arthritis on the pharmacokinetics of hydroxychloroquine enantiomers in rats. Pharm Res (1998) 0.80
Reassessing models of hepatic extraction. J Biol Phys (2003) 0.79
An interactive computer program for determining areas bounded by drug concentration curves using lagrange interpolation. J Pharmacol Toxicol Methods (1995) 0.79
The pharmacokinetics of captopril in infants with congestive heart failure. Ther Drug Monit (1991) 0.79
In vivo phenolic metabolites of N-alkylamphetamines in the rat. Evidence in favor of catechol formation. Drug Metab Dispos (1976) 0.79
Fungal metabolism of (-)-deprenyl and pargyline. Life Sci (1981) 0.79
Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function. J Pharm Sci (1992) 0.79
Metabolism and disposition of N-(2-cyanoethyl)amphetamine (fenproporex) and amphetamine: study in the rat brain. Can J Physiol Pharmacol (1986) 0.79
Determination of p-trifluoromethylphenol, a metabolite of fluoxetine, in tissues and body fluids using an electron-capture gas chromatographic procedure. J Chromatogr B Biomed Sci Appl (1997) 0.79
N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain. Pharm Res (1987) 0.79
In vitro metabolism of 1-phenyl-2-(n-propylamino) propane (N-propylamphetamine) by rat liver homogenates. J Pharm Pharmacol (1976) 0.79
N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.78
Effect of haemodialysis on metoclopramide kinetics in patients with severe renal failure. Br J Clin Pharmacol (1988) 0.78
Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine. Br J Pharmacol (1987) 0.78
Electron-capture gas chromatographic analysis of beta-phenylethylamine in tissues and body fluids using pentafluorobenzenesulfonyl chloride for derivatization. J Chromatogr (1986) 0.78
Osmotic load from glucose polymers. JPEN J Parenter Enteral Nutr (1991) 0.78
Failure to detect amphetamine or 1-amino-3-phenylpropane in humans or rats receiving the MAO inhibitor tranylcypromine. J Affect Disord (2000) 0.78
Synthesis and pharmacological evaluation of some , -disubstituted analogs of acetylcholine. J Med Chem (1972) 0.78
Metabolic acetylation of phenelzine in rats. Res Commun Chem Pathol Pharmacol (1988) 0.78
Recent studies on the MAO inhibitor phenelzine and its possible metabolites. J Neural Transm Suppl (1990) 0.78
Nonlinear pharmacokinetics of mibefradil in the dog. J Pharm Sci (1996) 0.78
Drug analysis at the 1988 Olympic Winter Games in Calgary. Clin Chem (1991) 0.78
Models of hepatic drug elimination. Drug Metab Rev (1992) 0.78
Effects of intravenous infusion of lidocaine on its pharmacokinetics in conscious instrumented dogs. J Pharm Sci (1997) 0.77
N-(3-chloropropyl)phenylethylamine as a possible prodrug of beta-phenylethylamine: studies in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.77
Adverse drug reactions and debrisoquine/sparteine (P450IID6) polymorphism in patients with fibromyalgia. Clin Rheumatol (1997) 0.77
Dosimetry estimations for 123I-IAZA in healthy volunteers. J Nucl Med (2001) 0.77
Analysis of imipramine and three metabolites produced by isozyme CYP2D6 expressed in a human cell line. Xenobiotica (1993) 0.77
Long-lasting elevation of alanine in brain produced by the antidepressant phenelzine. Brain Res Bull (1990) 0.77
A gas chromatographic procedure for separation and quantitation of the enantiomers of the antidepressant tranylcypromine. Biochem Pharmacol (1992) 0.77
Neurochemical and metabolic aspects of antidepressants: an overview. J Psychiatry Neurosci (2000) 0.77
Simplified determination of captopril in plasma by high-performance liquid chromatography. J Chromatogr (1988) 0.77
N,N-dipropargyl-2-phenylethylamine, a potential prodrug of 2-phenylethylamine: neurochemical and neuropharmacological studies in rat. Brain Res Bull (1987) 0.77
Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity. Dev Pharmacol Ther (1991) 0.77
Effects of acute and chronic administration of phenelzine on 2-phenylethylamine levels in rat brain. Proc West Pharmacol Soc (1982) 0.76
Conditioned place preferences, conditioned locomotion, and behavioral sensitization occur in rats treated with diethylpropion. Pharmacol Biochem Behav (1995) 0.76
Determination of 4-(4-chlorophenyl)-4-hydroxypiperidine, a metabolite of haloperidol, by gas chromatography with electron-capture detection. J Chromatogr B Biomed Appl (1996) 0.76
Analysis of amines in the central nervous system by gas chromatography with electron-capture detection. Prog Neurobiol (1981) 0.76
Pentafluorobenzenesulfonyl chloride as a sensitive reagent for the rapid gas chromatographic analysis of tranylcypromine in tissues and body fluids. Biochem Pharmacol (1986) 0.76
A comparison of the neurochemical properties of the stereoisomers of tranylcypromine in the central nervous system. Cell Mol Biol (1986) 0.76
Effects of chronic lithium and carbamazepine treatment on G-protein subunit expression in rat cerebral cortex. Biol Psychiatry (1993) 0.76
Human CYP2D6 and metabolism of m-chlorophenylpiperazine. Biol Psychiatry (1998) 0.76
A method for measurement of tranylcypromine in rat brain regions using gas chromatography with electron capture detection. Biochem Pharmacol (1981) 0.76
A rapid electron-capture gas chromatographic method for the quantification of fluvoxamine in brain tissue. J Pharmacol Toxicol Methods (1997) 0.76
Effects of taurine supplementation in parenteral nutrition-associated hepatosteatosis and lidocaine metabolism. A study using isolated rat liver perfusion. Drug Metab Dispos (1996) 0.76